- Messages
- 211
- Type of diabetes
- Type 1
- Treatment type
- Insulin
The device will, subject to local health authority approval, be available on the NHS across the United Kingdom from 1st November 2017.
You need to go back to your doctor and ask him if he was giving himself injections of a lethal substance multiple times a day whether he'd be happy to not have a way to monitor it safely.I'd love to try one as I am type 2 but only on insulin and having to fund my own test strips as doc says they are too expensive and fobbed me off with a rubbish meter!
On the other hand, if this also allows type 2s to be prescribed the Libre, think of this scenario. Instead of "You're type 2. Gliclazide and Sulphonyreas for you", the model is:
"Here, have a Libre for a month. Scan it 4x per day. I'll see you in two weeks to discuss the results". It potentially allows much better self-education about diet, and more importantly, if used in this way, gives the opportunity to see how destructive the recommended diet for T2 diabetes prescribed by the NHS is.
Potentially then, could this be the catalyst for better diet based treatment of T2.
Tim, do you think there is any possibility that those of us who'd prefer to use Dexcom (for whatever reason, whether that is for the alarms, due to adhesive reaction etc.) might be able to receive a partial contribution toward Dexcom costs equal to how much the NHS would otherwise spend on a Libre prescription? Is there any evidence of a contribution of this type having been made available in any other situations?So. A few thoughts on this announcement. The key points in the announcement come in the third paragraph:
Given the equivalent for lots of other treatments for various diseases, this does not mean it will be particularly available anywhere on 1st November. The precedent in these cases is for slowness rather than rapidity. It's a step in the right direction, but only that. It also makes the imposition of ridiculous conditions by authority very easy. I hope I'm wrong, but I feel this is set up to operate like CGM, without NICE guidelines to provide a national position. I therefore think it's going to be difficult to get hold of.
Secondly, what does it mean for access to CGM, which in my opinion is a better and more accurate system? I suspect that this has just made access to CGM considerably more difficult for many, and that funded CGM will come with the requirement that you will need to be completely hypo unaware, and you'll still be given Libre first. And if you have an adverse reaction to Libre glue, you are going to be stuffed.
I'm not so sure this is the great news that people think it is for Type 1.
On the other hand, if this also allows type 2s to be prescribed the Libre, think of this scenario. Instead of "You're type 2. Gliclazide and Sulphonyreas for you", the model is:
"Here, have a Libre for a month. Scan it 4x per day. I'll see you in two weeks to discuss the results". It potentially allows much better self-education about diet, and more importantly, if used in this way, gives the opportunity to see how destructive the recommended diet for T2 diabetes prescribed by the NHS is.
Potentially then, could this be the catalyst for better diet based treatment of T2.
I have tried but the contour next one test strips are apparently too expensive. They gave me the True You test meters and strips but I found it to be very unsatisfactory. My blood sugars were 85% out of range but using the next one they are now 95% within range.You need to go back to your doctor and ask him if he was giving himself injections of a lethal substance multiple times a day whether he'd be happy to not have a way to monitor it safely.
He's breaching NICE guidance on insulin use, as all insulin users are supposed to be prescribed test strips. I'd definitely go back and have a fight on that point. From the guideline for Type 2:
Self-monitoring of blood glucose
1.6.12Take the Driver and Vehicle Licensing Agency (DVLA) At a glance guide to the current medical standards of fitness to drive into account when offering self‑monitoring of blood glucose levels for adults with type 2 diabetes. [new 2015]
1.6.13Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless:
- the person is on insulin or
- there is evidence of hypoglycaemic episodes or
- the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or
- the person is pregnant, or is planning to become pregnant. For more information, see the NICE guideline on diabetes in pregnancy. [new 2015]